Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P54
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -7.72% |
| Q2 2025 | -29.74% |
| Q1 2025 | -36.68% |
| Q4 2024 | -8.07% |
| Q3 2024 | -35.54% |
| Q2 2024 | 48.71% |
| Q1 2024 | 11.65% |
| Q4 2023 | -103.49% |
| Q3 2023 | 62.14% |
| Q2 2023 | -215.79% |
| Q1 2023 | 165.39% |
| Q4 2022 | -33.69% |
| Q3 2022 | 22.21% |
| Q2 2022 | -66.86% |
| Q1 2022 | 79.24% |
| Q4 2021 | -271.70% |
| Q3 2021 | -34.90% |
| Q2 2021 | -18.92% |
| Q1 2021 | 45.61% |
| Q4 2020 | -244.67% |
| Q3 2020 | -28.26% |
| Q2 2020 | 45.22% |
| Q1 2020 | 1.77% |
| Q4 2019 | 15.03% |
| Q3 2019 | -11.71% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |